Non-extracorporeal membrane oxygenation artificial circulatory support devices

Cardiogenic shock is a common cause of morbidity and mortality in the hospital. The management remains challenging despite innovation and advances in therapeutic options. Mechanical circulatory support (MCS) devices to (temporarily) augment the cardiac output and promote cardiac recovery are increasingly being used in this patient population. While waiting for recovery, long-term artificial support, or a heart donor for heart transplantation, the heart can be supported with, but not limited to, intraaortic balloon pump (IABP), Impella devices, and even a left ventricular assist device (LVAD), with excellent results. North America and Europe constitute the largest markets for MCS use. However, MCS usage is increasing with an increase in expertise in Asia and Africa. Adequate management of patients requiring short-term MCS and the possible complications is necessary to minimize the risk of long-term morbidity and mortality.